# Operationalizing DNMT1-Targeting to Treat Chemorefractory Pancreatic Cancer

> **NIH NIH R21** · CLEVELAND CLINIC LERNER COM-CWRU · 2022 · $188,169


## Key facts

- **NIH application ID:** 10435230
- **Project number:** 1R21CA263430-01A1
- **Recipient organization:** CLEVELAND CLINIC LERNER COM-CWRU
- **Principal Investigator:** Yogen Saunthararajah
- **Activity code:** R21 (R01, R21, SBIR, etc.)
- **Funding institute:** NIH
- **Fiscal year:** 2022
- **Award amount:** $188,169
- **Award type:** 1
- **Project period:** 2022-03-01 → 2024-02-28

## Primary source

NIH RePORTER: https://reporter.nih.gov/project-details/10435230

## Citation

> US National Institutes of Health, RePORTER application 10435230, Operationalizing DNMT1-Targeting to Treat Chemorefractory Pancreatic Cancer (1R21CA263430-01A1). Retrieved via AI Analytics 2026-06-25 from https://api.ai-analytics.org/grant/nih/10435230. Licensed CC0.

---

*[NIH grants dataset](/datasets/nih-grants) · CC0 1.0*